CA
NZ
UK
AU
IND
US
Serina Therapeutics (NYSE American: SER) said the U.S. Food and Drug Administration gave constructive feedback that supports advancing SER-252, a POZ-enabled apomorphine formulation aimed at treating advanced Parkinson’s disease, via a 505(b)(2) NDA pathway. The company plans to launch a registrational clinical development program …
Porch Group (NASDAQ: PRCH) saw a notable shift in sell-side sentiment this month after the company reported second-quarter results and updated FY-2025 guidance. While some analysts pushed price objectives higher, Zacks Research moved its recommendation the other way — downgrading the stock from a …
Boeing (NYSE: BA) this week secured a landmark commitment from Korean Air for 103 aircraft, marking the carrier’s largest single order and Boeing’s largest widebody commitment from an Asian airline. Signed during the Korea–U.S. Business Roundtable, the agreement spans long-range and single-aisle types: 20 …
Index Update:Markets are focused on key earnings this week, with Nvidia and CrowdStrike reporting Wednesday, followed by Dell and Marvell on Thursday, and on Friday’s release of the Fed’s preferred inflation gauge, the PCE index. Wall Street rallied strongly Friday after Fed Chair Powell …
Hamilton Insurance Group Ltd. (NYSE: HG) currently carries an average recommendation of “Hold” from eight sell-side firms that have published ratings within the past year. The group’s average 12-month price target sits at USD 25.4286, indicating modest upside from recent trading levels but little …
Genpact Limited (NYSE: G) currently carries a consensus recommendation of “Hold” from seven research firms tracked by MarketBeat. The distribution tilts neutral—four “hold” ratings and three “buy”—with an average 12-month price objective of USD 52.2857. The cluster suggests modest expected appreciation but little agreement …
Eisai Co., Ltd. and Biogen Inc. announced the first European launches of LEQEMBI® (lecanemab) in Austria on August 25, 2025, with Germany to follow on September 1, 2025 — the initial rollout following the European Commission’s marketing authorisation in April 2025. These are the …
argenx reported positive topline results from the Phase 3 ADAPT SERON study evaluating VYVGART® (efgartigimod) in patients with AChR-Ab seronegative generalized myasthenia gravis (gMG). The trial achieved its primary endpoint, with a reported p-value of 0.0068 for improvement on the Myasthenia Gravis Activities of …
Canadian Pacific Kansas City (CPKC) used its role as title sponsor of the 2025 CPKC Women’s Open to deliver what organisers called a record fundraising outcome: AUD-equivalentUSD 4.5 millionraised for cardiac healthcare in Ontario, split between MacKids (McMaster Children’s Hospital) and Trillium Health Partners.
TotalEnergies and its partners Equinor and Shell announced the successful transport and subsea injection of the first CO₂ volumes from Heidelberg Materials’ cement plant in Brevik to Northern Lights’ facilities in Øygarden. The CO₂ was injected about 2,600 metres below the seabed, roughly 100 …
Please wait processing your request...